PortfoliosLab logoPortfoliosLab logo
CI vs. CROX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CI vs. CROX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cigna Corporation (CI) and Crocs, Inc. (CROX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CI achieves a 9.50% return, which is significantly lower than CROX's 45.83% return. Over the past 10 years, CI has underperformed CROX with an annualized return of 9.98%, while CROX has yielded a comparatively higher 28.24% annualized return.


CI

1D
1.07%
1M
-0.33%
YTD
9.50%
6M
9.71%
1Y
-3.41%
3Y*
5.04%
5Y*
6.20%
10Y*
9.98%

CROX

1D
-0.92%
1M
28.66%
YTD
45.83%
6M
38.71%
1Y
20.31%
3Y*
2.80%
5Y*
2.80%
10Y*
28.24%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CI vs. CROX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CI
Cigna Corporation
9.50%1.72%-6.27%-7.97%46.68%12.29%1.83%7.70%-6.46%52.29%
CROX
Crocs, Inc.
45.83%-21.92%17.26%-13.85%-15.43%104.63%49.58%61.24%105.54%84.26%

Correlation

The correlation between CI and CROX is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Feb 8, 2006

0.22

The correlation between CI and CROX shifts across timeframes, from 0.09 (3 years) to 0.22 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CI:

$78.68B

CROX:

$6.32B

EPS

CI:

$23.59

CROX:

-$1.94

PS Ratio

CI:

0.29

CROX:

1.65

PB Ratio

CI:

1.86

CROX:

4.43

Total Revenue (TTM)

CI:

$277.94B

CROX:

$4.02B

Gross Profit (TTM)

CI:

$19.38B

CROX:

$2.34B

EBITDA (TTM)

CI:

$10.03B

CROX:

$297.04M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CI vs. CROX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CI
CI Risk / Return Rank: 3737
Overall Rank
CI Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
CI Sortino Ratio Rank: 3434
Sortino Ratio Rank
CI Omega Ratio Rank: 3434
Omega Ratio Rank
CI Calmar Ratio Rank: 3939
Calmar Ratio Rank
CI Martin Ratio Rank: 3838
Martin Ratio Rank

CROX
CROX Risk / Return Rank: 5656
Overall Rank
CROX Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
CROX Sortino Ratio Rank: 5353
Sortino Ratio Rank
CROX Omega Ratio Rank: 5656
Omega Ratio Rank
CROX Calmar Ratio Rank: 5757
Calmar Ratio Rank
CROX Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CI vs. CROX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cigna Corporation (CI) and Crocs, Inc. (CROX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CICROXDifference
Sharpe ratioReturn per unit of total volatility

-0.49

Sortino ratioReturn per unit of downside risk

-0.78

Omega ratioGain probability vs. loss probability

1.01

1.13

-0.12

Calmar ratioReturn relative to maximum drawdown

-0.13

0.63

-0.76

Martin ratioReturn relative to average drawdown

-0.23

1.06

-1.30

CI vs. CROX - Sharpe Ratio Comparison

The current CI Sharpe Ratio is -0.10, which is lower than the CROX Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of CI and CROX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CI vs. CROX - Drawdown Comparison

The maximum CI drawdown since its inception was -84.34%, smaller than the maximum CROX drawdown of -98.74%. Use the drawdown chart below to compare losses from any high point for CI and CROX.


Loading charts...

Drawdown Indicators


CICROXDifference

Max Drawdown

Largest peak-to-trough decline

-84.34%

-98.74%

+14.40%

Max Drawdown (1Y)

Largest decline over 1 year

-26.54%

-32.54%

+6.00%

Max Drawdown (3Y)

Largest decline over 3 years

-32.10%

-54.04%

+21.94%

Max Drawdown (5Y)

Largest decline over 5 years

-32.10%

-73.86%

+41.76%

Max Drawdown (10Y)

Largest decline over 10 years

-42.47%

-75.18%

+32.71%

Current Drawdown

Current decline from peak

-15.81%

-30.94%

+15.13%

Average Drawdown

Average peak-to-trough decline

-18.82%

-61.29%

+42.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.58%

19.16%

-4.58%

Volatility

CI vs. CROX - Volatility Comparison

The current volatility for Cigna Corporation (CI) is 8.88%, while Crocs, Inc. (CROX) has a volatility of 12.30%. This indicates that CI experiences smaller price fluctuations and is considered to be less risky than CROX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CICROXDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.88%

12.30%

-3.42%

Volatility (6M)

Calculated over the trailing 6-month period

18.91%

32.47%

-13.56%

Volatility (1Y)

Calculated over the trailing 1-year period

33.22%

52.96%

-19.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.41%

55.19%

-26.78%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.75%

56.00%

-25.25%

Dividends

CI vs. CROX - Dividend Comparison

CI's dividend yield for the trailing twelve months is around 2.06%, while CROX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
CI
Cigna Corporation
2.06%2.19%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%
CROX
Crocs, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

CI vs. CROX - Financials Comparison

This section allows you to compare key financial metrics between Cigna Corporation and Crocs, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
68.49B
921.46M
(CI) Total Revenue
(CROX) Total Revenue
Values in USD except per share items

CI vs. CROX - Profitability Comparison

The chart below illustrates the profitability comparison between Cigna Corporation and Crocs, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%50.0%60.0%202220232024202520260
56.8%
Portfolio components
CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a gross profit of 0.00 and revenue of 68.49B. Therefore, the gross margin over that period was 0.0%.

CROX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Crocs, Inc. reported a gross profit of 522.95M and revenue of 921.46M. Therefore, the gross margin over that period was 56.8%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported an operating income of 2.36B and revenue of 68.49B, resulting in an operating margin of 3.4%.

CROX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Crocs, Inc. reported an operating income of 200.84M and revenue of 921.46M, resulting in an operating margin of 21.8%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a net income of 1.65B and revenue of 68.49B, resulting in a net margin of 2.4%.

CROX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Crocs, Inc. reported a net income of 137.56M and revenue of 921.46M, resulting in a net margin of 14.9%.


Frequently Asked Questions


CI and CROX have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CROX has higher volatility (12.30%) compared to CI (8.88%). In terms of maximum drawdown, CI dropped -84.34% vs CROX's -98.74%.

CROX currently has the higher Sharpe Ratio (0.39 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CI and CROX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer